## Abstract Biparatopic CEA, carcinoembryonic antigen (MAb) was newly designed and tested as to whether it enhanced the accuracy of tumor detection by reducing non‐specific binding in experimental radioimmunoguided surgery. Biparatopic MAb was prepared by using cross‐linking of reduced Fab′ fragmen
Experimental studies of tumor radioimmunodetection using antibody mixtures against carcinoembryonic antigen (CEA) and colon-specific antigen-p (CSAp)
✍ Scribed by Shaik A. Gaffar; Keshab D. Pant; Dan Shochat; Sidney J. Bennett; David M. Goldenberg
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- French
- Weight
- 478 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Experiments with the GW‐39 human colonic carcinoma growing in hamsters showed that injection of radioactive antibody to a colorectal‐specific, tumor‐associated antigen, CSAp, results in better tumor radiolocalization than was seen previously with radioantibodies to carcinoembryonic antigen (CEA). However, a mixture of both radioactive antibodies resulted in potentiation of CEA‐tumor radioimmunodetection without affecting CSAp‐tumor radiolocalization. Hence, multi‐marker antibody mixtures may be the method of choice in cancer radioimmunodetection.
📜 SIMILAR VOLUMES